The two vaccine-making giants plan to launch a 35,000-person study in the next few weeks,...
More about 'glaxosmithkline'
Sanofi and GlaxoSmithKline say their Covid-19 vaccine triggers a strong immune response
Andrew Dunn, Business Insider US
GSK, CureVac making 'next-generation' vaccines they say can tackle multiple Covid-19 variants at once
The new GSK-CureVac mRNA vaccines will target coronavirus variants and could be available...
Dr. Catherine Schuster-Bruce, Business Insider US
Glass vial shortage could stop global rollout of coronavirus vaccine
Vaccines are stored in glass vials, which are running low, slow to produce, and...
Bill Bostock, Business Insider US